Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2025)

Tarsus Pharmaceuticals (TARS) has 3 years of Change in Inventory data on record, last reported at $536000.0 in Q4 2025.

  • For Q4 2025, Change in Inventory rose 336.12% year-over-year to $536000.0; the TTM value through Dec 2025 reached $1.8 million, down 14.42%, while the annual FY2025 figure was $1.8 million, 14.42% down from the prior year.
  • Change in Inventory reached $536000.0 in Q4 2025 per TARS's latest filing, up from -$37000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.1 million in Q4 2023 and bottomed at -$227000.0 in Q4 2024.
  • Average Change in Inventory over 3 years is $690400.0, with a median of $594000.0 recorded in 2024.
  • The widest YoY moves for Change in Inventory: up 4246.67% in 2024, down 107.34% in 2024.
  • A 3-year view of Change in Inventory shows it stood at $3.1 million in 2023, then crashed by 107.34% to -$227000.0 in 2024, then surged by 336.12% to $536000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $536000.0 in Q4 2025, -$37000.0 in Q3 2025, and $1.2 million in Q2 2025.